Bhatnagar et al., 2017 - Google Patents
Potential role of Vδ2+ γδ T cells in regulation of immune activation in primary HIV infectionBhatnagar et al., 2017
View HTML- Document ID
- 16463965304462317627
- Author
- Bhatnagar N
- Girard P
- Lopez-Gonzalez M
- Didier C
- Collias L
- Jung C
- Bollens D
- Duvivier C
- Von Platen C
- Scott-Algara D
- Weiss L
- ANRS EP-56 Group
- Publication year
- Publication venue
- Frontiers in Immunology
External Links
Snippet
Although conventional regulatory T cells (Tregs) are sufficient in controlling low residual T- cell activation in ART-treated patients, they are not efficient in controlling exaggerated immune activation associated with high levels of HIV replication in primary HIV infection …
- 210000001744 T-Lymphocytes 0 title abstract description 128
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bhatnagar et al. | Potential role of Vδ2+ γδ T cells in regulation of immune activation in primary HIV infection | |
Asano et al. | PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy | |
Chase et al. | Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation | |
Fahey et al. | Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells | |
Peppa et al. | Adaptive reconfiguration of natural killer cells in HIV-1 infection | |
Day et al. | PD-1 expression on Mycobacterium tuberculosis-specific CD4 T cells is associated with bacterial load in human tuberculosis | |
Pitard et al. | Long-term expansion of effector/memory Vδ2− γδ T cells is a specific blood signature of CMV infection | |
Forcade et al. | Circulating T follicular helper cells with increased function during chronic graft-versus-host disease | |
Baecher-Allan et al. | MHC class II expression identifies functionally distinct human regulatory T cells | |
Herrmann et al. | Analysis of co-inhibitory receptor expression in COVID-19 infection compared to acute plasmodium falciparum malaria: lAG-3 and TIM-3 correlate with t cell activation and course of disease | |
Crellin et al. | Human NKp44+ IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells | |
Kang et al. | Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus | |
Vahlenkamp et al. | Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+ CD25+ T regulatory cells | |
Cunill et al. | Follicular T cells from smB− common Variable immunodeficiency Patients are skewed Toward a Th1 Phenotype | |
Martin-Gayo et al. | Circulating CXCR5+ CXCR3+ PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth | |
Dean et al. | Innate inflammation drives NK cell activation to impair Treg activity | |
Eken et al. | Fingolimod alters tissue distribution and cytokine production of human and murine innate lymphoid cells | |
Lam et al. | Co-infection of cytomegalovirus and Epstein-Barr virus diminishes the frequency of CD56dimNKG2A+ KIR− NK cells and contributes to suboptimal control of EBV in immunosuppressed children with post-transplant lymphoproliferative disorder | |
Kaminski et al. | Characterization of a unique γδ T-cell subset as a specific marker of cytomegalovirus infection severity | |
Liu et al. | Inverse correlation of Vδ2+ T‐cell recovery with EBV reactivation after haematopoietic stem cell transplantation | |
Chevalier et al. | CD4 T-cell responses in primary HIV infection: interrelationship with immune activation and virus burden | |
Vivar et al. | Survival and proliferation of CD28-T cells during HIV-1 infection relate to the amplitude of viral replication | |
Peng et al. | Dynamic immune landscape and VZV-specific T cell responses in patients with herpes zoster and postherpetic neuralgia | |
Singh et al. | Functional invariant natural killer T cells secreting cytokines are associated with non-progressive human immunodeficiency virus-1 infection but not with suppressive anti-retroviral treatment | |
Caldirola et al. | Immune monitoring of patients with primary immune regulation disorders unravels higher frequencies of follicular T cells with different profiles that associate with alterations in B cell subsets |